Literature DB >> 10851553

[DNA repeats and homologous recombination: a probable role for DNA methylation in genome stability of eukaryotic cells].

V Colot1, L Maloisel, J L Rossignol.   

Abstract

Homologous recombination between DNA repeats directly threatens the intact transmission of repeat-rich eukaryotic genomes through mitotic and meiotic cell divisions. Besides several other factors already known, DNA methylation might contribute, in some eukaryotes, to the limitation of crossover events between repeats. A strong inhibitory effect of DNA methylation has now been directly demonstrated, in the filamentous fungus Ascobolus. This therefore reinforces the question of the biological impact of this DNA modification on the recombinational stability of repeat-rich genomes, such as those of mammals.

Mesh:

Substances:

Year:  1999        PMID: 10851553

Source DB:  PubMed          Journal:  J Soc Biol        ISSN: 1295-0661


  4 in total

1.  Specific Alu elements involved in a significant percentage of copy number variations of the STK11 gene in patients with Peutz-Jeghers syndrome.

Authors:  Pawel Borun; Marina De Rosa; Boguslaw Nedoszytko; Jaroslaw Walkowiak; Andrzej Plawski
Journal:  Fam Cancer       Date:  2015-09       Impact factor: 2.375

2.  A Mechanism Leading to Changes in Copy Number Variations Affected by Transcriptional Level Might Be Involved in Evolution, Embryonic Development, Senescence, and Oncogenesis Mediated by Retrotransposons.

Authors:  Yunpeng Sui; Shuanghong Peng
Journal:  Front Cell Dev Biol       Date:  2021-02-11

3.  Promoter methylation and expression of TIMP3 gene in gastric cancer.

Authors:  ZhiYu Guan; Jun Zhang; ShiHui Song; DongQiu Dai
Journal:  Diagn Pathol       Date:  2013-07-02       Impact factor: 2.644

4.  Overexpression of Ribosomal RNA in the Development of Human Cervical Cancer Is Associated with rDNA Promoter Hypomethylation.

Authors:  Hong Zhou; Yapei Wang; Qiongying Lv; Juan Zhang; Qing Wang; Fei Gao; Haoli Hou; Hao Zhang; Wei Zhang; Lijia Li
Journal:  PLoS One       Date:  2016-10-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.